Search alternatives:
point decrease » point increase (Expand Search)
ann decrease » nn decrease (Expand Search), a decrease (Expand Search), gain decreased (Expand Search)
ms decrease » a decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
_ decrease » _ decreased (Expand Search)
10 point » _ point (Expand Search), 5 point (Expand Search), a point (Expand Search)
_ ann » _ any (Expand Search), _ ant (Expand Search), _ anc (Expand Search)
point decrease » point increase (Expand Search)
ann decrease » nn decrease (Expand Search), a decrease (Expand Search), gain decreased (Expand Search)
ms decrease » a decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
_ decrease » _ decreased (Expand Search)
10 point » _ point (Expand Search), 5 point (Expand Search), a point (Expand Search)
_ ann » _ any (Expand Search), _ ant (Expand Search), _ anc (Expand Search)
-
1
-
2
-
3
DART-ID decreases missing datapoints across runs.
Published 2019“…Only peptides seen in >50% of experiments are included. (<b>b</b>) Decrease in missing data across all runs after applying DART-ID, for SCoPE-MS and the two bulk sets from <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1007082#pcbi.1007082.g004" target="_blank">Fig 4</a> at 1% FDR. …”
-
4
-
5
-
6
-
7
-
8
-
9
-
10
SLE decreases risk for hormonal cancers.
Published 2021“…(b) Prostate cancer incidence in male SLE cohort is significantly decreased by SLE status (OR 0.23, 95% CI 0.089, 0.50, p = 0.0053).…”
-
11
Loss of C9orf72 decreases mTOR activation.
Published 2016“…Cells were starved for 50 min before being supplemented with amino acids for 10–20 min prior to lysate collection. …”
-
12
-
13
Changes in the concentration of IL-10 in each group at different time points after injury ().
Published 2023Subjects: -
14
-
15
-
16
-
17
-
18
-
19
The distribution of variables in PCR+ participants with detectable antibodies grouped as decreased, unchanged, increased, and antibody level ≥ 10 at time point T1 and T2.
Published 2022“…<p>The distribution of variables in PCR+ participants with detectable antibodies grouped as decreased, unchanged, increased, and antibody level ≥ 10 at time point T1 and T2.…”
-
20